NAVB Chart
- 52-Week Range: $0.72 - $2.00
- Market Capitalization: $24.76M
- Short Percentage: 0%
- Target Price: $5.00
- Shares Outstanding: 30.30M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
NAVB released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Navidea Biopharmaceuticals Receives Acceptance Letter from NYSE AmericanBusiness Wire | April 12th
- Navidea Biopharmaceuticals, Inc. (NAVB) Q4 2021 Results - Earnings Call TranscriptSeeking Alpha | March 23rd
- Navidea Biopharmaceuticals Reports Fourth Quarter 2021 Financial ResultsBusiness Wire | March 23rd
- Navidea Biopharmaceuticals to Host Fourth Quarter 2021 Earnings Conference Call and Business UpdateBusiness Wire | March 16th
- Navidea Biopharmaceuticals Announces Launch of Phase 3 Clinical Trial in Rheumatoid ArthritisBusiness Wire | December 16th
Company Info
Website: https://www.navidea.com
Address: 4995 Bradenton Avenue, Dublin, OH, United States, 43017-3552
Sector: Healthcare
Industry: Biotechnology
Full time employees: 11
Address: 4995 Bradenton Avenue, Dublin, OH, United States, 43017-3552
Sector: Healthcare
Industry: Biotechnology
Full time employees: 11
$NAVB lfg!!! So much movement ! Buy n hodl!
$NAVB my lotto for earnings
$NAVB bag holders for life club
$NAVB due for a spike!
$NAVB Rug pull soon?
$NAVB is being added
$NAVB longer we hold
more pressure on the shorts